{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:58:59Z","timestamp":1787317139610,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48056-7","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:34:45Z","timestamp":1776090885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A web-based prediction model using routinely available clinical variables to estimate surgical risk in Crohn\u2019s disease during remission or mild activity"],"prefix":"10.1038","volume":"16","author":[{"given":"Kailing","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengchang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"10080","key":"48056_CR1","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres, J. et al. Crohns disease. Lancet 389(10080), 1741\u20131755 (2017).","journal-title":"Lancet"},{"issue":"10432","key":"48056_CR2","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger, M., Torres, J. & Vermeire, S. Crohns disease. Lancet 403(10432), 1177\u20131191 (2024).","journal-title":"Lancet"},{"issue":"8067","key":"48056_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","volume":"642","author":"L Hracs","year":"2025","unstructured":"Hracs, L. et al. Global evolution of inflammatory bowel disease across epidemiologic stages. Nature 642(8067), 458\u2013466 (2025).","journal-title":"Nature"},{"issue":"6","key":"48056_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41575-025-01063-x","volume":"22","author":"V Solitano","year":"2025","unstructured":"Solitano, V. et al. Shaping the future of inflammatory bowel disease: A global research agenda for better management and public health response. Nat. Rev. Gastroenterol. Hepatol. 22(6), 438\u2013452 (2025).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"48056_CR5","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan, G. G. The global burden of IBD: From 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 12(12), 720\u2013727 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"48056_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2489067","volume":"17","author":"M Nagayama","year":"2025","unstructured":"Nagayama, M., Gogokhia, L. & Longman, R. S. Precision microbiota therapy for IBD: Premise and promise. Gut. Microbes. 17(1), 2489067 (2025).","journal-title":"Gut. Microbes."},{"issue":"1","key":"48056_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","volume":"15","author":"L Petagna","year":"2020","unstructured":"Petagna, L. et al. Pathophysiology of Crohns disease inflammation and recurrence. Biol. Direct. 15(1), 23 (2020).","journal-title":"Biol. Direct."},{"issue":"10","key":"48056_CR8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.crohns.2014.03.009","volume":"8","author":"F Rieder","year":"2014","unstructured":"Rieder, F. et al. Results of the 4th scientific workshop of the ECCO (Group II): Markers of intestinal fibrosis in inflammatory bowel disease. J. Crohns Colitis 8(10), 1166\u20131178 (2014).","journal-title":"J. Crohns Colitis"},{"issue":"4","key":"48056_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/gutjnl-2011-301397","volume":"61","author":"CN Bernstein","year":"2012","unstructured":"Bernstein, C. N. et al. Hospitalisations and surgery in Crohns disease. Gut 61(4), 622\u2013629 (2012).","journal-title":"Gut"},{"issue":"12","key":"48056_CR10","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1097\/MEG.0000000000002839","volume":"36","author":"J Du","year":"2024","unstructured":"Du, J. et al. A novel computed tomography enterography radiomics combining intestinal and creeping fat features could predict surgery risk in patients with Crohns disease. Eur. J. Gastroenterol. Hepatol. 36(12), 1384\u20131392 (2024).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"40","key":"48056_CR11","doi-asserted-by":"publisher","first-page":"8892","DOI":"10.3748\/wjg.v22.i40.8892","volume":"22","author":"JW Toh","year":"2016","unstructured":"Toh, J. W. et al. Indications and surgical options for small bowel, large bowel and perianal Crohns disease. World J. Gastroenterol. 22(40), 8892\u20138904 (2016).","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"48056_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrgastro.2016.158","volume":"13","author":"KV Patel","year":"2016","unstructured":"Patel, K. V. et al. Patient optimization for surgery relating to Crohns disease. Nat. Rev. Gastroenterol. Hepatol. 13(12), 707\u2013719 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"48056_CR13","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.cgh.2020.10.039","volume":"19","author":"L Tsai","year":"2021","unstructured":"Tsai, L. et al. Contemporary risk of surgery in patients with Ulcerative colitis and Crohns disease: A meta-analysis of population-based cohorts. Clin. Gastroenterol. Hepatol. 19(10), 2031-2045. (2021).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"36","key":"48056_CR14","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.3748\/wjg.14.5532","volume":"14","author":"R Al\u00f3s","year":"2008","unstructured":"Al\u00f3s, R. & Hinojosa, J. Timing of surgery in Crohns disease: A key issue in the management. World. J. Gastroenterol. 14(36), 5532\u20135539 (2008).","journal-title":"World. J. Gastroenterol."},{"issue":"5","key":"48056_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jviscsurg.2016.04.009","volume":"153","author":"JS Lee","year":"2016","unstructured":"Lee, J. S. et al. The importance of the Crohns Disease Activity Index in surgery for small bowel Crohns disease. J. Visc. Surg. 153(5), 339\u2013345 (2016).","journal-title":"J. Visc. Surg."},{"issue":"6","key":"48056_CR16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00384-021-03857-2","volume":"36","author":"EM Meima-van Praag","year":"2021","unstructured":"Meima-van Praag, E. M. et al. Surgical management of Crohns disease: A state of the art review. Int. J. Colorectal Dis. 36(6), 1133\u20131145 (2021).","journal-title":"Int. J. Colorectal Dis."},{"issue":"3","key":"48056_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ibd\/izac211","volume":"29","author":"P Chirra","year":"2023","unstructured":"Chirra, P. et al. Integrating Radiomics with clinicoradiological scoring can predict high-risk patients who need surgery in Crohns disease: A pilot study. Inflamm. Bowel. Dis. 29(3), 349\u2013358 (2023).","journal-title":"Inflamm. Bowel. Dis."},{"issue":"46","key":"48056_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017510","volume":"98","author":"Y Dong","year":"2019","unstructured":"Dong, Y. et al. A novel surgical predictive model for Chinese Crohns disease patients. Med. (Baltimore) 98(46), e17510 (2019).","journal-title":"Med. (Baltimore)"},{"issue":"9","key":"48056_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19942","volume":"9","author":"R Liu","year":"2023","unstructured":"Liu, R. et al. Development and validation of multiparametric models based on computed tomography enterography to determine endoscopic activity and surgical risk in patients with Crohns disease: A multi-center study. Heliyon. 9(9), e19942 (2023).","journal-title":"Heliyon."},{"issue":"8","key":"48056_CR20","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cgh.2024.12.030","volume":"23","author":"GR Madsen","year":"2025","unstructured":"Madsen, G. R. et al. Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohns Disease: A Copenhagen IBD Cohort Study. Clin. Gastroenterol. Hepatol. 23(8), 1398-1407. (2025).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"48056_CR21","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1016\/j.acra.2023.03.023","volume":"30","author":"L Ruiqing","year":"2023","unstructured":"Ruiqing, L. et al. A novel radiomics model integrating luminal and mesenteric features to predict mucosal activity and surgery risk in Crohns disease patients: A multicenter study. Acad. Radiol. 30(Suppl 1), S207-s219 (2023).","journal-title":"Acad. Radiol."},{"issue":"1","key":"48056_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00384-023-04456-z","volume":"38","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Quantitative analysis of adipose tissue for predicting Crohns disease postoperative endoscopic recurrence and anastomotic ulcer. Int. J. Colorectal Dis. 38(1), 170 (2023).","journal-title":"Int. J. Colorectal Dis."},{"issue":"4","key":"48056_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00535-018-1505-8","volume":"54","author":"A Buisson","year":"2019","unstructured":"Buisson, A. et al. Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohns disease. J. Gastroenterol. 54(4), 312\u2013320 (2019).","journal-title":"J. Gastroenterol."},{"issue":"21","key":"48056_CR24","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp, R. L., Dolled-Filhart, M. & Rimm, D. L. X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer. Res. 10(21), 7252\u20137259 (2004).","journal-title":"Clin. Cancer. Res."},{"issue":"1","key":"48056_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00384-024-04725-5","volume":"39","author":"L Yang","year":"2024","unstructured":"Yang, L. et al. Epidemiological investigation of different types of Crohns disease patients undergoing first abdominal surgery in the era of biological agents: a population-based cohort study. Int. J. Colorectal. Dis. 39(1), 150 (2024).","journal-title":"Int. J. Colorectal. Dis."},{"issue":"2","key":"48056_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MEG.0b013e32835a7eed","volume":"25","author":"RM Cerqueira","year":"2013","unstructured":"Cerqueira, R. M. & Lago, P. M. Clinical factors predictive of Crohns disease complications and surgery. Eur. J. Gastroenterol. Hepatol. 25(2), 129\u2013134 (2013).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"Suppl A","key":"48056_CR27","doi-asserted-by":"publisher","first-page":"5a","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg, M. S. et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 19(Suppl A), 5a\u201336a (2005).","journal-title":"Can. J. Gastroenterol."},{"issue":"6","key":"48056_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi, J. et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6), 749\u2013753 (2006).","journal-title":"Gut"},{"key":"48056_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1425168","volume":"15","author":"HH Zhou","year":"2024","unstructured":"Zhou, H. H. et al. C-reactive protein: Structure, function, regulation, and role in clinical diseases. Front. Immunol. 15, 1425168 (2024).","journal-title":"Front. Immunol."},{"issue":"1","key":"48056_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S2468-1253(21)00299-5","volume":"7","author":"H Yanai","year":"2022","unstructured":"Yanai, H. et al. The Crohns disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohns disease (CDED-AD): An open-label, pilot, randomised trial. Lancet. Gastroenterol. Hepatol. 7(1), 49\u201359 (2022).","journal-title":"Lancet. Gastroenterol. Hepatol."},{"issue":"6","key":"48056_CR31","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ajg.2015.120","volume":"110","author":"MH Mosli","year":"2015","unstructured":"Mosli, M. H. et al. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients A Systematic Review and Meta-Analysis. Am. J. Gastroenterol. 110(6), 802\u2013819 https:\/\/journals.lww.com\/ajg\/abstract\/2015\/06000\/c_reactive_protein,_fecal_calprotectin,_and_stool.10.asp (2015).","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"48056_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12876-021-02040-9","volume":"21","author":"XF Chen","year":"2021","unstructured":"Chen, X. F. et al. Predictive value of fibrinogen in identifying inflammatory bowel disease in active stage. BMC Gastroenterol. 21(1), 472 (2021).","journal-title":"BMC Gastroenterol."},{"key":"48056_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109799","volume":"116","author":"L Fu","year":"2023","unstructured":"Fu, L., Liu, Z. & Liu, Y. Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target. Int. Immunopharmacol. 116, p. 109799 (2023).","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"48056_CR34","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.3892\/mmr.2017.7005","volume":"16","author":"H Lin","year":"2017","unstructured":"Lin, H. et al. Elevated fibrinogen-like protein 2 in TNBS-induced colitis mice: association with Th17 and regulatory T cells. Mol. Med. Rep. 16(3), 3445\u20133454 (2017).","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"48056_CR35","first-page":"649","volume":"112","author":"B Hoppe","year":"2014","unstructured":"Hoppe, B. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation. Thromb. Haemost. 112(4), 649\u2013658 (2014).","journal-title":"Thromb. Haemost."},{"issue":"3","key":"48056_CR36","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/ATVBAHA.117.308564","volume":"37","author":"S Kattula","year":"2017","unstructured":"Kattula, S., Byrnes, J. R. & Wolberg, A. S. Fibrinogen and fibrin in hemostasis and thrombosis. Arterioscler. Thromb. Vasc. Biol. 37(3), e13\u2013e21 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"48056_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","volume":"34","author":"D Davalos","year":"2012","unstructured":"Davalos, D. & Akassoglou, K. Fibrinogen as a key regulator of inflammation in disease. Semin. Immunopathol. 34(1), 43\u201362 (2012).","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"48056_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1055\/s-0041-1732467","volume":"48","author":"KJ Kearney","year":"2022","unstructured":"Kearney, K. J., Ari\u00ebns, R. A. S. & Macrae, F. L. The role of fibrin(ogen) in wound healing and infection control. Semin. Thromb. Hemost. 48(2), 174\u2013187 (2022).","journal-title":"Semin. Thromb. Hemost."},{"key":"48056_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.916187","volume":"13","author":"A Seltana","year":"2022","unstructured":"Seltana, A. et al. Fibrin(ogen) is constitutively expressed by differentiated intestinal epithelial cells and mediates wound healing. Front. Immunol. 13, p. 916187 (2022).","journal-title":"Front. Immunol."},{"key":"48056_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27144504","author":"IS Bayer","year":"2022","unstructured":"Bayer, I. S. Advances in fibrin-based materials in wound repair: A review. Molecules https:\/\/doi.org\/10.3390\/molecules27144504 (2022).","journal-title":"Molecules"},{"issue":"12","key":"48056_CR41","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1097\/01.MIB.0000437041.59208.44","volume":"19","author":"D Owczarek","year":"2013","unstructured":"Owczarek, D. et al. Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: A novel prothrombotic mechanism. Inflamm. Bowel Dis. 19(12), 2616\u20132624 (2013).","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"48056_CR42","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1152\/physrev.00014.2021","volume":"102","author":"BA Molitoris","year":"2022","unstructured":"Molitoris, B. A. et al. Albumin uptake and processing by the proximal tubule: physiological, pathological, and therapeutic implications. Physiol. Rev. 102(4), 1625\u20131667 (2022).","journal-title":"Physiol. Rev."},{"issue":"5","key":"48056_CR43","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.26338","volume":"58","author":"R Garcia-Martinez","year":"2013","unstructured":"Garcia-Martinez, R. et al. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 58(5), 1836\u20131846 (2013).","journal-title":"Hepatology"},{"issue":"6","key":"48056_CR44","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jhep.2022.03.005","volume":"76","author":"P Caraceni","year":"2022","unstructured":"Caraceni, P., OBrien, A. & Gines, P. Long-term albumin treatment in patients with cirrhosis and ascites. J. Hepatol. 76(6), 1306\u20131317 (2022).","journal-title":"J. Hepatol."},{"issue":"11","key":"48056_CR45","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/ibd\/izad310","volume":"30","author":"P Alvisi","year":"2024","unstructured":"Alvisi, P. et al. Major abdominal surgery for pediatric Crohns disease in the anti-TNF era: 10-year analysis of data from the IBD Registry of Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Inflamm. Bowel Dis. 30(11), 2087\u20132096 (2024).","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"48056_CR46","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/ibd\/izac167","volume":"29","author":"P Rivi\u00e8re","year":"2023","unstructured":"Rivi\u00e8re, P. et al. Comparative effectiveness of Ustekinumab and anti-TNF agent as first-line biological therapy in luminal Crohns disease: A retrospective study from 2 referral centers. Inflamm. Bowel Dis. 29(6), 923\u2013931 (2023).","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"48056_CR47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00535-018-1511-x","volume":"54","author":"Y Nagata","year":"2019","unstructured":"Nagata, Y. et al. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohns disease of inflammatory type. J. Gastroenterol. 54(4), 330\u2013338 (2019).","journal-title":"J. Gastroenterol."},{"issue":"1","key":"48056_CR48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/ecco-jcc\/jjv187","volume":"10","author":"Y Gonz\u00e1lez-Lama","year":"2016","unstructured":"Gonz\u00e1lez-Lama, Y. et al. Timing of Thiopurine or anti-TNF initiation is associated with the risk of major abdominal surgery in Crohns disease: A retrospective cohort study. J. Crohns Colitis 10(1), 55\u201360 (2016).","journal-title":"J. Crohns Colitis"},{"key":"48056_CR49","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820931738","volume":"13","author":"AB Quaresma","year":"2020","unstructured":"Quaresma, A. B., Yamamoto, T. & Kotze, P. G. Biologics and surgical outcomes in Crohns disease: Is there a direct relationship?. Therap. Adv. Gastroenterol. 13, p. 1756284820931738 (2020).","journal-title":"Therap. Adv. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48056-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:02:39Z","timestamp":1780574559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48056"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48056-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study was approved by the Ethics Committee of Xiangya Second Hospital (Ethics ID: LYEC2025-0156), and followed the Declaration of Helsinki. Patient data were anonymized throughout the study. As this was a retrospective study, informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"17259"}}